Providers watch these changes closely because they affect nutrition, hydration, medication tolerance, weight management, and dose decisions
These changes may start imperceptibly but slowly become more noticeable as time progresses
Report any unusual symptoms or concerns promptly so they can be addressed before becoming serious problems
CBO expects the above-noted cost per user to go down as more competitors enter the market (though CBO notes that brand prices may not drop if the drugs get better as manufacturers compete on quality as well as price), more generic alternatives appear, more people use AOMs and for longer periods of time, as well as if beneficiaries who were already on AOMs prior to joining Medicare continued their treatment
That lowers the entry point
A disclosure up front: YourHealthier sells a GLP-1 Companion supplement that falls in the companion category (vitamins and minerals for people on GLP-1 medications)